House panel backs licensing for outpatient substance use treatment with amendment after fiscal, staffing debate

Chair Maureen Mooney, chair of House Finance Division III, convened the work session on Sept. 29 and said the panel would review retained bills including House Bill 751, which would require licensure of outpatient substance use disorder (SUD) treatment facilities and create a complaint-investigation function for the Department of Health and Human Services (DHHS) Office of the Ombudsman.

The committee adopted language that narrowed the bill's scope and reduced the fiscal impact, then voted 6-4 to recommend the bill "ought to pass as amended" to full finance.

Why it matters: Supporters said licensing outpatient providers will close oversight gaps that leave some patients exposed and create consistent quality standards. Opponents and some members flagged the cost and uncertainty about how many outpatient providers currently operate outside Medicaid or DHHS contracts, and whether the department's existing licensing bureau can absorb new responsibilities with only one additional position.

DHHS officials and advocates

Jenny O'Higgins, legislative liaison for behavioral health at DHHS, described how the bill evolved during the policy process from a separate…